1. Home
  2. LPCN vs SWIN Comparison

LPCN vs SWIN Comparison

Compare LPCN & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • SWIN
  • Stock Information
  • Founded
  • LPCN 1997
  • SWIN 2017
  • Country
  • LPCN United States
  • SWIN Hong Kong
  • Employees
  • LPCN N/A
  • SWIN N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • SWIN
  • Sector
  • LPCN Health Care
  • SWIN
  • Exchange
  • LPCN Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • LPCN 36.8M
  • SWIN 41.7M
  • IPO Year
  • LPCN N/A
  • SWIN 2023
  • Fundamental
  • Price
  • LPCN $4.71
  • SWIN $2.51
  • Analyst Decision
  • LPCN Strong Buy
  • SWIN
  • Analyst Count
  • LPCN 1
  • SWIN 0
  • Target Price
  • LPCN $10.00
  • SWIN N/A
  • AVG Volume (30 Days)
  • LPCN 28.3K
  • SWIN 105.8K
  • Earning Date
  • LPCN 11-07-2024
  • SWIN 11-29-2024
  • Dividend Yield
  • LPCN N/A
  • SWIN N/A
  • EPS Growth
  • LPCN N/A
  • SWIN N/A
  • EPS
  • LPCN N/A
  • SWIN N/A
  • Revenue
  • LPCN $7,922,926.00
  • SWIN $3,437,000.00
  • Revenue This Year
  • LPCN N/A
  • SWIN N/A
  • Revenue Next Year
  • LPCN N/A
  • SWIN N/A
  • P/E Ratio
  • LPCN N/A
  • SWIN N/A
  • Revenue Growth
  • LPCN N/A
  • SWIN N/A
  • 52 Week Low
  • LPCN $2.38
  • SWIN $2.01
  • 52 Week High
  • LPCN $11.79
  • SWIN $72.55
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 41.11
  • SWIN 46.05
  • Support Level
  • LPCN $4.64
  • SWIN $2.15
  • Resistance Level
  • LPCN $4.98
  • SWIN $2.60
  • Average True Range (ATR)
  • LPCN 0.51
  • SWIN 0.23
  • MACD
  • LPCN -0.12
  • SWIN 0.00
  • Stochastic Oscillator
  • LPCN 5.12
  • SWIN 50.72

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

Share on Social Networks: